Chodup P, Samodelov S, Visentin M, Kullak-Ublick G
Liver Int. 2025; 45(2):e70002.
PMID: 39853863
PMC: 11760653.
DOI: 10.1111/liv.70002.
Dwarakanath D, Nayak Y, Kulal A, Pandey S, Pai K, Gaonkar S
Sci Rep. 2024; 14(1):31994.
PMID: 39738776
PMC: 11685468.
DOI: 10.1038/s41598-024-83498-x.
Liang Y, Li J, Zhang L, Zhou J, Liu M, Peng X
Thorac Cancer. 2024; 16(2):e15495.
PMID: 39723644
PMC: 11735728.
DOI: 10.1111/1759-7714.15495.
Verso M, Moik F, Graziani M, Cohen A
Haematologica. 2024; 109(12):3868-3878.
PMID: 39618297
PMC: 11609817.
DOI: 10.3324/haematol.2023.284778.
Jimenez-Cortegana C, Sanchez-Jimenez F, de la Cruz-Merino L, Sanchez-Margalet V
Int J Mol Med. 2024; 55(1).
PMID: 39450529
PMC: 11537268.
DOI: 10.3892/ijmm.2024.5444.
The effectiveness of targeted therapy for recurrence or metastasis adenoid cystic carcinoma: a systematic review and meta-analysis.
Zhang L, Yang H, Wang Y, Li D, Lei Z, Yang M
Ann Med. 2024; 56(1):2399867.
PMID: 39258959
PMC: 11391875.
DOI: 10.1080/07853890.2024.2399867.
Discovery of therapeutic targets in cancer using chromatin accessibility and transcriptomic data.
Forbes A, Xu D, Cohen S, Pancholi P, Khurana E
Cell Syst. 2024; 15(9):824-837.e6.
PMID: 39236711
PMC: 11415227.
DOI: 10.1016/j.cels.2024.08.004.
Advances in Personalized Oncology.
Mechahougui H, Gutmans J, Colarusso G, Gouasmi R, Friedlaender A
Cancers (Basel). 2024; 16(16).
PMID: 39199633
PMC: 11352922.
DOI: 10.3390/cancers16162862.
Mechanisms of resistance to tyrosine kinase inhibitor-targeted therapy and overcoming strategies.
Ou X, Gao G, Habaz I, Wang Y
MedComm (2020). 2024; 5(9):e694.
PMID: 39184861
PMC: 11344283.
DOI: 10.1002/mco2.694.
Enhancing sepsis biomarker development: key considerations from public and private perspectives.
Llitjos J, Carrol E, Osuchowski M, Bonneville M, Scicluna B, Payen D
Crit Care. 2024; 28(1):238.
PMID: 39003476
PMC: 11246589.
DOI: 10.1186/s13054-024-05032-9.
Global Gene Expression Profiling and Bioinformatics Analysis Reveal Downregulated Biomarkers as Potential Indicators for Hepatocellular Carcinoma.
Mestareehi A
ACS Omega. 2024; 9(24):26075-26096.
PMID: 38911766
PMC: 11191119.
DOI: 10.1021/acsomega.4c01496.
Effect of functionalization on the adsorption performance of carbon nanotube as a drug delivery system for imatinib: molecular simulation study.
Rezazade M, Ketabi S, Qomi M
BMC Chem. 2024; 18(1):85.
PMID: 38678270
PMC: 11555890.
DOI: 10.1186/s13065-024-01197-0.
Selective Recognition of G-Quadruplex by Structural Tuning of Heteroaromatic Scaffolds and Side Chains.
Fatma K, Thumpati P, Panda D, Velayutham R, Dash J
ACS Med Chem Lett. 2024; 15(3):388-395.
PMID: 38505840
PMC: 10945540.
DOI: 10.1021/acsmedchemlett.3c00537.
Discovery of a small-molecule NDR1 agonist for prostate cancer therapy.
Bai Y, Sui X, Xuan Z, Du Y, Fu M, Zheng Z
Front Pharmacol. 2024; 15:1367358.
PMID: 38410130
PMC: 10896269.
DOI: 10.3389/fphar.2024.1367358.
New Derivatives of 1-(3-Methyl-1-Benzofuran-2-yl)Ethan-1-one: Synthesis and Preliminary Studies of Biological Activity.
Napiorkowska M, Kumaravel P, Amboo Mahentheran M, Kiernozek-Kalinska E, Grosicka-Maciag E
Int J Mol Sci. 2024; 25(4).
PMID: 38396676
PMC: 10888192.
DOI: 10.3390/ijms25041999.
Forward or Backward: Lessons Learned from Small Molecule Drugs Approved by FDA from 2012 to 2022.
Gu M, Sun S, You Q, Wang L
Molecules. 2023; 28(24).
PMID: 38138431
PMC: 10745639.
DOI: 10.3390/molecules28247941.
RIPTACs: A groundbreaking approach to drug discovery.
Ma Z, Bolinger A, Zhou J
Drug Discov Today. 2023; 28(11):103774.
PMID: 37734702
PMC: 11144445.
DOI: 10.1016/j.drudis.2023.103774.
SFyNCS detects oncogenic fusions involving non-coding sequences in cancer.
Zhong X, Luan J, Yu A, Lee-Hassett A, Miao Y, Yang L
Nucleic Acids Res. 2023; 51(18):e96.
PMID: 37638762
PMC: 10570049.
DOI: 10.1093/nar/gkad705.
Navigating drug repurposing for Chagas disease: advances, challenges, and opportunities.
Porta E, Kalesh K, Steel P
Front Pharmacol. 2023; 14:1233253.
PMID: 37576826
PMC: 10416112.
DOI: 10.3389/fphar.2023.1233253.
Combination Effects of Integrin-linked Kinase and Abelson Kinase Inhibition on Aberrant Mitosis and Cell Death in Glioblastoma Cells.
Cunningham A, Brown M, Dresselhuis J, Robinson N, Hervie K, Cox M
Biology (Basel). 2023; 12(7).
PMID: 37508338
PMC: 10376030.
DOI: 10.3390/biology12070906.
